Skip to main content

NRC Health

NRC
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0000070487

No open-market purchases or sales by NRC Health insiders were filed in the last 90 days; 123 institutions reported holding it in 13F filings for Q2 2026, worth $231.9M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding NRC Health changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of NRC: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders1262119−5
Shares11.7M46111.1M−555.6K (−4.8%)
Value$196.1M$7.75K$142.0M−$54.1M (−27.6%)

2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held NRC Health at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to NRC in Q3 2025
InstitutionSharesValue% of portfolio
ExodusPoint Capital Management, LP22,838$291.9K0.00%
Graham Capital Management, L.P.20,701$264.6K0.01%
Inscription Capital, LLC10,724$137.1K0.01%
State of Alaska, Department of Revenue1,272$16.0K0.00%
Root Financial Partners, LLC1,000$12.8K0.00%
Quadrant Capital Group LLC621$7.94K0.00%
Advisory Services Network, LLC314$4.01K0.00%
Optiver Holding B.V.224$2.86K0.00%
Fifth Third Bancorp197$2.52K0.00%
Group One Trading, L.P.100$1.28K0.00%
Sunbelt Securities, Inc.18$2300.00%
Summit Wealth Group LLC4,561––

Sold out (17)

Institutions that held NRC Health at the end of Q2 2025 and filed for Q3 2025 without it.

Not filed for Q3 2025 yet (2)

Institutions that held NRC Health at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NRC in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
First Horizon Advisors, Inc.445$7.48K
Parkworth Wealth Management, Inc.16$269